WBA
66
2
SLG
27
2
BBY
53
-3
EIX
29
2
QRVO
32
2
AA
31
3
DOV
53
3
JBHT
56
3
STX
39
4
EXPE
77
2
CNP
57
3
CINF
31
3
NTRS
49
5
AIZ
56
7
GT
37
4
CI
38
3
EXPD
23
3
APH
55
5
TGT
53
-3
CVX
37
2
WBA
66
2
SLG
27
2
BBY
53
-3
EIX
29
2
QRVO
32
2
AA
31
3
DOV
53
3
JBHT
56
3
STX
39
4
EXPE
77
2
CNP
57
3
CINF
31
3
NTRS
49
5
AIZ
56
7
GT
37
4
CI
38
3
EXPD
23
3
APH
55
5
TGT
53
-3
CVX
37
2
Financhill
Back

Genpact Vs. Blueprint Medicines Industry Stock Comparison

Buy
62

G
Genpact

Last Price:
$44.21
Seasonality Move:
2.42%
Sell
40

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Buy
62
Genpact (G) is a Buy

Is Genpact a Buy, Sell or Hold?

  • The current Genpact [G] share price is $44.20. The Score for G is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • G is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

G Stock Price Chart

What is Genpact's stock price today?

  • The Genpact share price today is $44.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and G is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $102.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.

G Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 56.09 Buy
Chaikin Money Flow: -981301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.61 - 44.45) Buy
Bollinger Bands (100): (38.43 - 44.33) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 63.82 Buy
Chaikin Money Flow: -913925 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.06 - 96.6) Buy
Bollinger Bands (100): (86.99 - 95.95) Buy

G Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.55 Buy
20-day SMA: 43.19 Buy
50-day SMA: 43.89 Buy
200-day SMA: 37.11 Buy
8-day EMA: 43.64 Buy
20-day EMA: 43.56 Buy
50-day EMA: 43.05 Buy
200-day EMA: 39.16 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.93 Buy
20-day SMA: 91.76 Buy
50-day SMA: 93.83 Buy
200-day SMA: 96.87 Buy
8-day EMA: 94.89 Buy
20-day EMA: 92.92 Buy
50-day EMA: 92.72 Buy
200-day EMA: 91.71 Buy

Genpact Earnings Growth & G Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.32 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

Genpact Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):